期刊文献+

右心辅助在心脏移植术后急性右心衰竭中的临床应用 被引量:2

原文传递
导出
摘要 目的探讨右心辅助方式治疗合并重度肺动脉高压患者心脏移植术后急性右心衰竭的初步经验。方法回顾性分析2017年4~8月我院行右心辅助4例患者的临床资料,其中男3例、女1例,平均年龄(46.2±1.8)岁。术前行右心导管监测肺动脉阻力为(7.80±0.67)Wood单位,肺动脉收缩压(69.75±3.47)mm Hg。在心脏复跳后体外循环并行循环时行肺动脉和股静脉插管,建立右心室辅助并撤离体外循环。辅助至右心功能恢复满意,逐步减低流量,撤除右心辅助。结果 4例患者全部成功撤除右心辅助并存活。平均供心冷缺血时间为(235.0±18.8)min,体外循环时间为(272.0±41.1)min,并行辅助循环时间为(166.0±32.7)min,平均右心辅助时间为(157.7±27.5)h,全血激活凝固时间(ACT)监测波动于120~150 s之间。期间无再次开胸止血事件,无辅助机械障碍发生,无管道内凝血事件发生。结论右心辅助比体外膜肺氧合具有机械故障少,辅助时间长,抗凝要求低,出血少,血细胞、血小板和凝血因子破坏少的优点,而且经济效益可观,更加接近生理循环,不会增加左心后负荷。
出处 《中国胸心血管外科临床杂志》 CAS CSCD 2018年第10期906-909,共4页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 广东省科技计划项目(2017B030314109 2017B090904034 2017A070701013)
  • 相关文献

参考文献2

二级参考文献42

  • 1Chen JM, Levin HR, Michler RE, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg, 1997, 114(4):627-634.
  • 2Weston MW, Isaac BF, Crain C. The use of inhaled prostacyelin in nitroprusside resistant pulmonary artery hypertension. J Heart Lung Transplant, 2001,20(12) : 1340-1344.
  • 3Klotz S, Deng MC, Hanafy D, et al. Reversible pulmonary hypertension in heart transplant candidates-pretransplant evalualion and outcome after orthotopic heart transplantation. Eur J Heart Fail, 2003,5(5) :645-653.
  • 4Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol, 1992,19(1):48-54.
  • 5Delgado JF, GOmez Scinchez MA, Saenz de la Calzada C, et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant, 2001,20 (9) : 942-948.
  • 6Butler J, Stankewicz MA, Wu J, et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant, 2005,24(2): 170 177.
  • 7Klotz S, Wenzelburger pulmonary hypertension Stypmann J, et heart transplant al. Reversible candidates, to transplant or not to transplant. Ann Thorac Surg, 2006,82(5) 1770-1773.
  • 8Drakos SG, Kfoury AG, Gilbert EM, et al. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 2007,26(4):319-323.
  • 9Goland S, Czer LS, Kass RM, et al. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemoclynamic follow up after orthotopic heart transplantation. J Heart Lung Transplant, 2007,26 (4):312-318.
  • 10Braun S, Schrotter H, Schmeisser A, et al. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Int J Cardiol,2007,115(1): 67-72.

共引文献16

同被引文献4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部